Bevacizumab in cervical cancer: Balancing survival benefit and serious adverse events
Taiwanese Journal of Obstetrics & Gynecology
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Bevacizumab in cervical cancer: Balancing survival benefit and serious adverse events. // Taiwanese Journal of Obstetrics & Gynecology. – URL: https://www.sciencedirect.com/science/article/pii/S1028455926003116?dgcid=rss_sd_all
Bevacizumab in cervical cancer: Balancing survival benefit and serious adverse events. Taiwanese Journal of Obstetrics & Gynecology. https://www.sciencedirect.com/science/article/pii/S1028455926003116?dgcid=rss_sd_all
“Bevacizumab in cervical cancer: Balancing survival benefit and serious adverse events.” Taiwanese Journal of Obstetrics & Gynecology.
@article{article119580,
title = {Bevacizumab in cervical cancer: Balancing survival benefit and serious adverse events},
journal = {Taiwanese Journal of Obstetrics \& Gynecology},
url = {https://www.sciencedirect.com/science/article/pii/S1028455926003116?dgcid=rss_sd_all}
}